FONAR Corporation

NASDAQ:FONR

Medical - Devices

Healthcare
$19.09 +0.00%

+$0.00 today

Market cap
$117.76M
Beta
0.95
P/E (TTM)
17.6
EPS (TTM)
$1.08
52W Low $13.62High $19.16

Volume 0.00M

Average 0.08M

FONR Total Debt

Short-term and long-term borrowings combined.

FONAR CorporationNASDAQ: FONR

Total Debt · Q3 FY2026 · quarter ended Mar 2026

Total debt falls 2.4% from a year ago

Total debt stood at $38.83M at the end of Q3 FY2026, down 2.4% from a year earlier and down 2.4% from the prior quarter. Over 3 fiscal years it compounded at +0.6% a year.

Context

  • Total debt amounted to 17.7% of total assets at the end of Q3 FY2026, down 0.8 pp from a year earlier.
  • Total debt increased in 1 of the last 3 fiscal years.

What to watch

Whether total debt keeps falling in the next quarterly balance sheet after a -2.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$38.83M-2.4% QoQ
Last fiscal yearJun 2025
$38.92M-6.6% YoY
Year agoMar 2025
$39.79M-2.4% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-2.4%——
1 year-6.6%——
3-year CAGR+0.6%——
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
38.92M USD
Year-over-year change
-6.6%
4-year CAGR
+2.9%

Total Debt vs competitors

How FONR compares with its peers on the latest reported figures

  • Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -2.4% is the 5th highest of 8, against a peer median of -1.2%.
  • Total debt amounts to 17.7% of total assets for FONR, versus a peer median of 22.1%.
FONR Competitors
Total Debt for FONR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
LUNGPulmonx CorporationMar 2026$56.29M USD-1.2%+32.2%46.9%
APYXApyx Medical CorporationMar 2026$39.46M USD+1.4%+267.0%62.6%
FONRFONAR CorporationMar 2026$38.83M USD-2.4%+0.6%17.7%
VANIVivani Medical, Inc.Mar 2026$18.28M USD-3.5%+170.3%43.1%
HYPRHyperfine, Inc.Mar 2026$13.35M USD+4976.8%—22.1%
ARTVArtiva Biotherapeutics, Inc.Mar 2026$10.26M USD-26.7%-17.4%9.7%
RCELAVITA Medical, Inc.Mar 2026$1.98M USD-95.5%+268.8%3.8%
IFRXInflaRx N.V.Mar 2026€823.89K EUR+17.3%-12.9%1.7%
Peer median (excluding FONR) —-1.2%+101.2%22.1%

Competitors are the stored peer set for FONR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Cash & Equivalents44.46M48.72M51.28M56.34M56.33M
Short-term Investments32.18K32.33K32.8K136.1K120.49K
Net Receivables61.2M66.47M70.17M79.85M82.94M
Inventory1.66M2.36M2.57M2.72M2.81M
Other Current Assets0001.29M2.46M
Total Current Assets108.58M118.69M125.66M140.32M144.67M
Property, Plant & Equipment (Net)53.11M57.44M55.94M57.67M54.04M
Goodwill4.27M4.27M4.27M4.27M4.27M
Intangible Assets4.04M3.7M3.43M2.87M2.99M
Long-term Investments01.87M710.09K00
Tax Assets15.96M12.84M10.04M7.22M6.35M
Other Non-current Assets3.55M526.27K523.51K1.89M4.58M
Total Non-current Assets80.92M80.66M74.92M73.92M72.24M
Total Assets189.51M199.34M200.58M214.25M216.91M
Account Payables1.87M1.55M1.58M1.86M1.3M
Short-term Debt173.21K40.08K43.77K47K0
Tax Payables1.42M630.7K241.39K1.66M640.32K
Deferred Revenue5.11M4.65M4.43M4.31M5.22M
Other Current Liabilities943.24K1.07M785.75K1.6M1.89M
Total Current Liabilities20.05M16.75M15.62M17.86M17.12M
Long-term Debt760.25K155.38K115.08K66.94K0
Deferred Tax Liabilities238.32K215.73K394.76K371.56K321.16K
Deferred Revenue (Non-current)2.8M1.86M760.24K1.17M3.8M
Other Non-current Liabilities263.99K199.2K134.41K124.69K265.52K
Total Non-current Liabilities34.09M36.36M34.13M39.6M39.68M
Total Liabilities54.14M53.11M49.75M57.46M56.8M
Common Stock695695685673660
Retained Earnings(46.01M)(33.57M)(24.19M)(13.62M)(5.29M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest(3.05M)(4.05M)(7.08M)(9.18M)(12.5M)
Total Equity135.37M146.24M150.83M156.79M160.1M
Total Debt34.69M38.22M37.01M41.68M38.92M
Net Debt(9.77M)(10.51M)(14.27M)(14.67M)(17.42M)

FONAR Corporation

NASDAQ:FONR

Intrinsic Alpha fair value

Locked

Current Price

$19.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.